Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Imprimis Pharma
4121
Imprimis Pharma
Health Care
Technology
Biotechnology
Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) Delivering customized and other novel medicines to physicians and patients TODAY at accessible prices.
Suggest edits
Raised
$25.8M
Follow us
Also headquartered in San Diego
Qualcomm
Intuit
GoFundMe
Dan
Industry
Edge
Illumina
San Diego Comic-Con
ESET
Bandsintown
Companies in the same industry
Chimerix
Betalin Therapeutics Inc
Pneumagen
Merck
Invitae
ConforMIS
Sanovas
Ascension Orthopedics
doublehelix design
Provia Laboratories
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Latest funding
$16,000,000
Post-IPO debt - 2017
SWK Funding
$9,800,000
Post-IPO equity - 2016
Team Size
1–10
Employees
I work here
Location
San Diego
,
United States
Headquarters
Explore San Diego
$16,000,000
Post-IPO debt
otcmarkets
,
prnewswire
Imprimis Pharmaceuticals Announces $16 Million Debt Facility with SWK Holdings
$9,800,000
Post-IPO equity
StreetInsider.com
Imprimis Pharma (IMMY) Reports $9.8M Private Placement of Common stock and Warrants
